Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

No annotations are provided, so the description carries the full behavioral burden, and it discloses almost nothing: no indication of how molecules are aligned, whether missing/invalid SMILES cause failure, whether the call is a pure read, or what the comparison reports. Only the input cardinality is revealed.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Is the description appropriately sized, front-loaded, and free of redundancy?

A single short, front-loaded sentence with no wasted words; the 2-5 range is immediately visible. The brevity is efficient, though it is achieved by omission rather than by tight writing.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

An output schema exists so return values need not be described, but with zero annotation coverage and 0% schema description coverage the definition leaves the agent guessing on input format, auth via api_key, and when to pick this tool among the many compare siblings.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema description coverage is 0%, so the description must compensate for both parameters and does not. 'smiles_list' is only inferable from the word 'molecules', and the api_key parameter is never mentioned at all — an agent would not know it exists or what it does.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Does the description clearly state what the tool does and how it differs from similar tools?

The description states a verb (compare) and resource (molecules) and adds a size constraint (2-5). However, 'side by side' says nothing about what dimensions are compared (properties, scaffolds, similarity scores), and there is no differentiation from the several sibling compare tools (covair_compare, covnmr_compare, covauv_compare).

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Does the description explain when to use this tool, when not to, or what alternatives exist?

No guidance on when to choose this over alternatives such as covachem_profile or covabasic_similarity, nor any prerequisite or exclusion. Only the implicit 2-5 molecule range constrains use, and that is a format constraint, not usage guidance.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.